Inventor · disambiguated record
Anton Bespalov
Also filed as: BESPALOV ANTON
8 granted patents·10 pending applications·42 citations·filing 2008–2023
83Inventor score
Files withABBOTT GMBH & CO KG5ABBVIE DEUTSCHLAND2HAUPT ANDREAS2SYNVENTA LLC2VEPACHEDU SREENIVASARAO2
Top patents by PatentIndex Score
18 records- 0190US8076326B2N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2010·Granted Dec 13, 2011·23 cites·28 claims
- 0283US8183237B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2010·Granted May 22, 2012·4 cites·17 claims
- 0380US8343959B2N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2011·Granted Jan 1, 2013·5 cites·10 claims
- 0480US7790727B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2008·Granted Sep 7, 2010·4 cites·31 claims
- 0574US11103499B2Compositions and methods thereofEXCIVA UG HAFTUNGSBESCHRAENKT·Filed 2017·Granted Aug 31, 2021·4 cites·17 claims
- 0672US8362010B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2010·Granted Jan 29, 2013·2 cites·23 claims
- 0765US2023381144A1Compositions and methods for treatment of painSYNVENTA LLC·Filed 2023·Application pending·0 cites
- 0861US2015175570A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 0959US2014200224A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorABBVIE DEUTSCHLAND·Filed 2013·Application pending·0 cites
- 1055US2021228508A1Compositions and methods thereofExciva GmbH·Filed 2021·Application pending·0 cites
- 1153US2011319421A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorTURNER SEAN COLM·Filed 2011·Application pending·0 cites
- 1252US8492540B21,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorBRAJE WILFRIED·Filed 2008·Granted Jul 23, 2013·0 cites·20 claims
- 1352US2021155597A1Compositions and methods for treatment of painSYNVENTA LLC·Filed 2020·Application pending·0 cites
- 1448US2022296586A1Novel compositions, combinations, and methods thereofVEPACHEDU SREENIVASARAO·Filed 2022·Application pending·0 cites
- 1548US2013018047A1N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptorABBOTT LAB·Filed 2012·Application pending·0 cites
- 1643US2011086863A1Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptorABBOTT GMBH & CO KG·Filed 2010·Application pending·0 cites
- 1736US11478467B2Targeted drug rescue with novel compositions, combinations, and methods thereofVEPACHEDU SREENIVASARAO·Filed 2018·Granted Oct 25, 2022·0 cites·11 claims
- 1835US2011059983A1Use of substituted oxindole derivatives for the treatment and prophylaxis of painABBOTT GMBH & CO KG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anton Bespalov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →